SkinHealth Systems Inc. Class A Common Stock (SKIN)
Stock · NASDAQ · Health Care
$10.56as of 10/16/2026
Price chart
Active signals
SKIN Signal Track Record
How signals performed across all stocks →What SKIN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | -10.9% | 28% | September 8, 2026 |
| Bollinger Band Breakdown | 19 | -2.2% | 47% | September 29, 2026 |
| Bollinger Band Breakout | 20 | -11.7% | 20% | June 29, 2026 |
| 200-Day Moving Average TouchActive now | 6 | +4.0% | 50% | October 7, 2025 |
| Any 20-session window (baseline) | -4.4% | 40% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SKIN
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are deliv…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 613
- Website
- investors.beautyhealth.com
Fundamentals
- 1-day range
- $11.94$12.84
- Market cap
- $99.91M
- P/E (trailing)
- —
- P/E (forward)
- 3.23
- EPS (trailing)
- $-0.22
- Dividend yield
- —
- Beta
- 1.02
- Avg. volume
- 24.2K
How SkinHealth Systems Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
SkinHealth Systems Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- SKINSkinHealth Systems Inc. Class A Common Stock$10.56▼ 16.19%Market cap $99.91MP/E —$10.01$34.8
- PYPDPolyPid Ltd. Ordinary Shares$4.72▼ 3.67%Market cap $91.79MP/E —$3.1$5.73
- GUTSFractyl Health Inc. Common Stock$1.55▼ 62.74%Market cap $108.99MP/E —$3.78$29.34
- LUNGPulmonx Corporation Common Stock$1.78▼ 3.78%Market cap $88.04MP/E —$1.13$2.89
- MBOTMicrobot Medical Inc. Common Stock$0.95▲ 0.00%Market cap $120.90MP/E —$0.99$3.04
- LNSRLENSAR Inc. Common Stock$5.8▼ 3.81%Market cap $70.43MP/E 2.15$4.95$12.94
- XTNTXtant Medical Holdings Inc. Common Stock$0.29▼ 3.33%Market cap $62.09MP/E 23.84$0.2702$0.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SKIN SkinHealth Systems Inc. Class A Common Stock | $99.91M | — | $10.56 | ▼ 16.19% | $10.01$34.8 |
| PYPD PolyPid Ltd. Ordinary Shares | $91.79M | — | $4.72 | ▼ 3.67% | $3.1$5.73 |
| GUTS Fractyl Health Inc. Common Stock | $108.99M | — | $1.55 | ▼ 62.74% | $3.78$29.34 |
| LUNG Pulmonx Corporation Common Stock | $88.04M | — | $1.78 | ▼ 3.78% | $1.13$2.89 |
| MBOT Microbot Medical Inc. Common Stock | $120.90M | — | $0.95 | ▲ 0.00% | $0.99$3.04 |
| LNSR LENSAR Inc. Common Stock | $70.43M | 2.15 | $5.8 | ▼ 3.81% | $4.95$12.94 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $62.09M | 23.84 | $0.29 | ▼ 3.33% | $0.2702$0.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Michael P. Monahan · August 10, 2026 · Tax Withholding32.4K @ $0.64
Institutional Ownership
March 31, 2026
- Total shares held
- 79.66M
- Total value held
- $70.82M
- Institutional holders
- 112
- Unknown19.40M
- Unknown17.18M
- Unknown7.36M
- Unknown5.72M
- Unknown5.70M
- Unknown3.78M
- Unknown3.44M
- Unknown2.24M
- Unknown1.90M
- Unknown1.88M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SkinHealth Systems Expands SkinStylus MicroSystem to Europe
SkinHealth Systems announced that its SkinStylus® SteriLock® MicroSystem will now be available in European markets. The move expands the company’s footprint beyond North America and could broaden its customer base. The product is a sterilization platform used in dermatology. The news comes as the stock trades near its 52‑week low, but the expansion may support future growth.
SkinHealth Systems Expands SkinStylus MicroSystem to Europe. SkinHealth Systems announced that its SkinStylus® SteriLock® MicroSystem will now be available in European markets. The move expands the company’s footprint beyond North America and could broaden its customer base. The product is a sterilization platform used in dermatology. The news comes as the stock trades near its 52‑week low, but the expansion may support future growth.